These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24713234)

  • 1. Re: Kobuchi S, Tanaka R, Shintani T, Suzuki R, Tsutsui H, Ohkita M, Ayajiki K, and Matsumura Y (2011) mechanisms underlying the renoprotective effect of GABA against ischemia/reperfusion-induced renal injury in rats. J Pharmacol Exp Ther 338:767-774; doi:10.1124/jpet.111.180174.
    J Pharmacol Exp Ther; 2014 May; 349(2):347. PubMed ID: 24713234
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Ueda K, Tsuju F, Hirata T, Ueda K, Murai M, Aono H, Takaoka M, and Matsumura Y (2009) preventive effect of SA13353 [1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea], a novel transient receptor potential vanilloid 1 agonist, on ischemia/reperfusion-induced renal injury in rats. J Pharmacol Exp Ther 329:202-209; doi:10.1124/jpet.108.146241.
    J Pharmacol Exp Ther; 2014 May; 349(2):346. PubMed ID: 24713233
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Nakajima A, Ueda K, Takaoka M, Yoshimi Y, and Matsumura Y (2006) opposite effects of pre- and postischemic treatments with nitric oxide donor on ischemia/reperfusion-induced renal injury. J Pharmacol Exp Ther 316:1038-1046; doi:10.1124/jpet.105.092049.
    J Pharmacol Exp Ther; 2014 May; 349(2):345. PubMed ID: 24713232
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545-552; doi:10.1124/jpet.105.087643.
    J Pharmacol Exp Ther; 2014 Mar; 348(3):493. PubMed ID: 24534945
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Magierowski M, Jasnos K, Pawlik M, Krzysiek-Maczka G, Ptak-Belowska A, Olszanecki R, Kwiecien S, Korbut R, and Brzozowski T (2013) Role of Angiotensin-(1-7) in Gastroprotection against Stress-Induced Ulcerogenesis. The Involvement of Mas Receptor, Nitric Oxide, Prostaglandins, and Sensory Neuropeptides. J Pharmacol Exp Ther 347:717-726; doi:10.1124/jpet.113.207233.
    J Pharmacol Exp Ther; 2015 Jun; 353(3):563. PubMed ID: 25934764
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Yamashita J, Itoh M, Kuro T, Kobayashi Y, Ogata M, Takaoka m, and Matsumura Y (2001) pre- or post-ischemic treatment with a novel na+/ca2+ exchange inhibitor, kb-r7943, shows renal protective effects in rats with ischemic acute renal failure. J pharmacol exp ther 296:412-419.
    J Pharmacol Exp Ther; 2014 May; 349(2):344. PubMed ID: 24713231
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schönfeld P, Roessner A, and Gali-Muhtasib H (2005) 5-aza-Cytidine Is a Potent Inhibitor of DNA Methyltransferase 3a and Induces Apoptosis in HCT-116 Colon Cancer Cells via Gadd45- and p53-Dependent Mechanisms. J Pharmacol Exp Ther February 2005 312:525-536; doi:10.1124/jpet.104.074195.
    J Pharmacol Exp Ther; 2016 Oct; 359(1):90. PubMed ID: 27581647
    [No Abstract]   [Full Text] [Related]  

  • 8. Notice of Retraction: Harada S, Yamazaki Y, and Tokuyama S (2013) Orexin-A Suppresses Postischemic Glucose Intolerance and Neuronal Damage through Hypothalamic Brain-Derived Neurotrophic Factor,
    J Pharmacol Exp Ther; 2020 Nov; 375(2):397. PubMed ID: 33115940
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Norman AB, Tabet MR, Norman MK, and Tsibulsky VL (2014) Maintained Cocaine Self-Administration Is Determined by Quantal Responses: Implications for the Measurement of Antagonist Potency. J Pharmacol Exp Ther 348:311-315; doi:10.1124/jpet.113.210690.
    J Pharmacol Exp Ther; 2016 Aug; 358(2):241. PubMed ID: 27370348
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Kadam RS and Kompella UB (2010) Influence of Lipophilicity on Drug Partitioning into Sclera, Choroid-Retinal Pigment Epithelium, Retina, Trabecular Meshwork, and Optic Nerve. J Pharmacol Exp Ther 332:1107-1120; doi:10.1124/jpet.109.161570.
    J Pharmacol Exp Ther; 2015 Feb; 352(2):326. PubMed ID: 25542193
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms underlying the renoprotective effect of GABA against ischemia/reperfusion-induced renal injury in rats.
    Kobuchi S; Tanaka R; Shintani T; Suzuki R; Tsutsui H; Ohkita M; Ayajiki K; Matsumura Y
    J Pharmacol Exp Ther; 2011 Sep; 338(3):767-74. PubMed ID: 21632868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notice of Concern: McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, and Harding JW (2013) Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents,
    J Pharmacol Exp Ther; 2021 Sep; 378(3):313. PubMed ID: 34551989
    [No Abstract]   [Full Text] [Related]  

  • 13. Notice of Concern: Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, and Harding JW (2012) Development of Angiotensin IV Analogs as Hepatocyte Growth Factor/Met Modifiers,
    J Pharmacol Exp Ther; 2021 Sep; 378(3):314. PubMed ID: 34551990
    [No Abstract]   [Full Text] [Related]  

  • 14. Notice of Concern: Kawas LH, Yamamoto BJ, Wright JW, and Harding JW (2011) Mimics of the Dimerization Domain of Hepatocyte Growth Factor Exhibit Anti-Met and Anticancer Activity,
    J Pharmacol Exp Ther; 2021 Sep; 378(3):312. PubMed ID: 34551988
    [No Abstract]   [Full Text] [Related]  

  • 15. Notice of Concern: Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, and Harding JW (2014) The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System,
    J Pharmacol Exp Ther; 2021 Sep; 378(3):311. PubMed ID: 34551987
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms underlying the renoprotective effect of GABA against ischaemia/reperfusion-induced renal injury in rats.
    Kobuchi S; Tanaka R; Shintani T; Suzuki R; Tsutsui H; Ohkita M; Matsumura Y; Ayajiki K
    Clin Exp Pharmacol Physiol; 2015 Mar; 42(3):278-86. PubMed ID: 25482107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effects of gamma-aminobutyric acid on ischemia/reperfusion-induced renal injury in rats.
    Kobuchi S; Shintani T; Sugiura T; Tanaka R; Suzuki R; Tsutsui H; Fujii T; Ohkita M; Ayajiki K; Matsumura Y
    Eur J Pharmacol; 2009 Nov; 623(1-3):113-8. PubMed ID: 19765583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective effects of l-carnosine on ischemia/reperfusion-induced renal injury in rats.
    Kurata H; Fujii T; Tsutsui H; Katayama T; Ohkita M; Takaoka M; Tsuruoka N; Kiso Y; Ohno Y; Fujisawa Y; Shokoji T; Nishiyama A; Abe Y; Matsumura Y
    J Pharmacol Exp Ther; 2006 Nov; 319(2):640-7. PubMed ID: 16916994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications.
    Sullivan TJ; Dairaghi DJ; Krasinski A; Miao Z; Wang Y; Zhao BN; Baumgart T; Berahovich R; Ertl LS; Pennell A; Seitz L; Miao S; Ungashe S; Wei Z; Johnson D; Boring L; Tsou CL; Charo IF; Bekker P; Schall TJ; Jaen JC
    J Pharmacol Exp Ther; 2012 Jun; ():. PubMed ID: 22378937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats.
    Kim SH; Jun JH; Oh JE; Shin EJ; Oh YJ; Choi YS
    PLoS One; 2018; 13(8):e0198307. PubMed ID: 30114208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.